Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2007
03/08/2007WO2007025751A1 Use of fused imidazole derivatives to mediate ccr3 related conditions
03/08/2007WO2007025575A1 O-hydroxy- and o-amino benzamide derivatives as ikk2 inhibitors
03/08/2007WO2007025540A2 Substituted imidazo[1,2b]pyridazines as kinase inhibitors, the production thereof, and use of the same as medicaments
03/08/2007WO2007025488A1 Method of production of fine-crystalline mixture containing non-steroid anti-inflammatory drug, fine-crystalline mixture obtainable by this method and solid pharmaceutical composition containing this mixture
03/08/2007WO2007025366A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents
03/08/2007WO2007025351A1 Tissue disruption treatment and composition for use thereof
03/08/2007WO2006108572A3 Novel crystalline pharmaceutical product
03/08/2007WO2006105741A3 Topical pharmaceutical formulation containing nimesulide
03/08/2007WO2006099445A3 Nanocells for diagnosis and treatment of diseases and disorders
03/08/2007WO2006027579A3 The treatment of inflammatory disorders and pain
03/08/2007WO2003020702A3 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/08/2007US20070054962 Method for treating acute or chronic pain
03/08/2007US20070054923 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054922 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054920 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
03/08/2007US20070054904 Phenol derivatives and their use as rotamase inhibitors
03/08/2007US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists
03/08/2007US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy
03/08/2007US20070054898 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054878 Use of hyaluronic acid derivatives for inhibiting inflammatory arthritis
03/08/2007US20070054861 Therapeutic uses of SMR1 peptides
03/08/2007US20070054364 Polypeptide variants
03/08/2007US20070053994 Anti-inflammatory treatment
03/08/2007US20070053926 Antigenic neisserial peptides
03/08/2007US20070053902 Anti-alphabeta3 humanized monoclonal antibodies
03/08/2007US20070053849 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
03/08/2007CA2670130A1 Heterobifunctional pan-selectin inhibitors
03/08/2007CA2625940A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents
03/08/2007CA2624316A1 Tissue disruption treatment and composition for use thereof
03/08/2007CA2621229A1 Non-steroidal compounds useful as glucocorticoid receptor modulators
03/08/2007CA2621083A1 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins
03/08/2007CA2620834A1 Use of fused imidazole derivatives to mediate ccr3 related conditions
03/08/2007CA2620742A1 Thiomorpholine compound and process for preparing the same
03/08/2007CA2620740A1 Pyridazinone derivatives used for the treatment of pain
03/08/2007CA2620534A1 Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
03/08/2007CA2607999A1 Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid
03/07/2007EP1760083A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
03/07/2007EP1759710A1 Remedy or preventive for arthritis
03/07/2007EP1759709A1 Humanized antibodies against leukocyte adhesion molecule VLA-4
03/07/2007EP1758915A2 Composition and method for inhibiting platelet aggregation
03/07/2007EP1758653A2 Treatments comprising strontium for rheumatic and arthritic diseases and pain
03/07/2007EP1758652A2 Improving pain treatment with strontium combinations
03/07/2007EP1758579A1 Crth2 receptor ligands for medicinal uses
03/07/2007EP1758573A1 A pharmaceutical composition and its use
03/07/2007EP1758572A1 Combinations of hyaluronic acid and polyunsaturated fatty acids
03/07/2007EP1685131B1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
03/07/2007EP1462101B1 Drinkable preparation comprising ketoprofen and use thereof in the simultaneous treatment of a group of animals of respiratory diseases
03/07/2007EP1450780B1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
03/07/2007EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1
03/07/2007EP1427728B1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES
03/07/2007EP1372651B1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
03/07/2007EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof
03/07/2007EP1223808B1 Peripheral cannabinoid receptor (cb2) selective ligands
03/07/2007EP1043998B1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDANT KINASE INHIBITORS
03/07/2007EP1009752B1 Novel molecules of the tango-77 related protein family and uses thereof
03/07/2007EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics
03/07/2007CN1925872A Method of preventing ultraviolet ray-induced apoptosis
03/07/2007CN1925861A Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
03/07/2007CN1925846A Use of a 5-HT3 receptor antagonist for the manufacture of a medicament for the treatment of non-digestive tract derived abdominal disorders associated with pain
03/07/2007CN1925841A Pharmaceutical preparation for the oral cavity
03/07/2007CN1924015A Important regulation albumen ChK2 of NF-KB signal path
03/07/2007CN1923798A Preparation method of dexibuprofen amino acid salt and application
03/07/2007CN1923797A Pharmaceutical compounds
03/07/2007CN1923276A Important regulation protein PAK7 of NF[kappa]B signal path
03/07/2007CN1923263A Traditional Chinese medicine composition, its preparing method and quality controlling means
03/07/2007CN1923230A Medicine for treating rheumatism and rheumatoid disease, and its preparation method
03/07/2007CN1923193A Application of cumarin kind compound in preparation of antiphlogistic and analgetic medicine
03/07/2007CN1923176A Oil-in-water baicalin nano-milk oral liquid and its preparing process
03/07/2007CN1923168A External use plaster for treating acute jerk contused wound
03/07/2007CN1303072C 7-oxo pyridopyrimidines
03/07/2007CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/07/2007CN1303059C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
03/07/2007CN1302811C Externally-applicated chewing gum including chip-like center
03/07/2007CN1302771C 2-(4-isobutylphenyl) propionic acid medicinal composition
03/07/2007CN1302769C Aqueous injection of curcuma oil extract and preparation process and use
03/06/2007US7186864 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma
03/06/2007US7186859 Uses for amino acid anticonvulsants
03/06/2007US7186841 Antiinflammation agents
03/06/2007US7186840 Quinoline derivatives as anti-inflammatory agents
03/06/2007US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
03/06/2007US7186826 Phosphorus-containing compounds and uses thereof
03/06/2007US7186820 Antibody for use in the treatment of rheumatic and osteoarthritis
03/06/2007US7186810 Modified peptides as therapeutic agents
03/06/2007US7186803 Human vanilloid receptor VR3 protein
03/06/2007US7186802 Membrane proteins; for treatment of inflammation, asthma, allergy, metastasis of cancer cells, ion transport disorders such as magnesium defects in the kidney, and inflammatory bowel disease
03/06/2007US7186755 Carboxyvinylpolymer neutralized as a gel-forming agent or a polyacrylamide-isoparaffin and ethanol, isopropanol or diethylene glycol monoethyl ether as a solvent
03/06/2007US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents
03/06/2007US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
03/06/2007US7186748 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
03/06/2007US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
03/06/2007US7186737 Inhibitors of p38
03/06/2007US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders
03/06/2007US7186725 Anti-inflammatory compositions and methods
03/06/2007US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases
03/06/2007US7186718 For therapy of autoimmune, inflammatory, proliferative and hyperproliferative diseases and immunologically-mediated diseases including rejection of transplanted organs or tissues and Acquired Immunodeficiency Syndrome (AIDS
03/06/2007US7186717 Pyrrolidine derivatives as Factor Xa inhibitors
03/06/2007US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders
03/06/2007US7186708 Steroidal compounds
03/06/2007US7186703 Derivatives of branched-chain lipophilic molecules and uses thereof
1 ... 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 ... 1272